USPSTF recommendation on statin use for primary prevention of cardiovascular disease

JAMA Network

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends that for primary prevention of cardiovascular disease (CVD) in adults ages 40 to 75 who have one or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking), clinicians should prescribe a statin for those with an estimated 10-year CVD risk of 10% or greater and selectively offer a statin for those with an estimated risk of 7.5% to less than 10%. The USPSTF concludes that the current evidence is insufficient to make a recommendation about initiating a statin for the primary prevention of CVD events and mortality in adults age 76 or older. Cardiovascular disease is the leading cause of death in the United States, the cause of more than 1 of every 4 deaths. The USPSTF routinely makes recommendations about the effectiveness of preventive care services, and this recommendation replaces and is generally consistent with its 2016 recommendation.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2022.13044)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.